-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Gene Therapy For Multiple Myeloma And Stem Cell Transplantation in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gene Therapy For Multiple Myeloma And Stem Cell Transplantation in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gene Therapy...
-
Product Insights
Hematopoietic Stem Cell Transplantation – Drugs In Development, 2023
Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Drugs In Development, 2023’, provides an overview of the Hematopoietic Stem Cell Transplantation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hematopoietic Stem Cell Transplantation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Limbal Stem Cell Deficiency (LSCD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Limbal Stem Cell Deficiency (LSCD) - Drugs In Development, 2023’, provides an overview of the Limbal Stem Cell Deficiency (LSCD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Limbal Stem Cell Deficiency (LSCD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Mast/Stem Cell Growth Factor Receptor Kit – Drugs In Development, 2023
Global Markets Direct’s Mast/Stem Cell Growth Factor Receptor Kit provides in depth analysis on Mast/Stem Cell Growth Factor Receptor Kit targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Stem Cell Therapy For Parkinson’s Disease in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Stem Cell Therapy For Parkinson's Disease in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Stem Cell Therapy For Parkinson's Disease in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Stem Cell Therapy For Lung Transplant Rejection in Lung Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Stem Cell Therapy For Lung Transplant Rejection in Lung Transplant Rejection report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Stem Cell Therapy For Lung...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mesenchymal Stem Cell (MSC) in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mesenchymal Stem Cell (MSC) in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mesenchymal Stem Cell (MSC)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Human Amniotic Epithelial Stem Cells in Premature Ovarian Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Human Amniotic Epithelial Stem Cells in Premature Ovarian Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Human Amniotic Epithelial Stem Cells in Premature...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Human Amniotic Epithelial Stem Cells in Graft Versus Host Disease (GVHD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Human Amniotic Epithelial Stem Cells in Graft Versus Host Disease (GVHD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Human Amniotic Epithelial Stem Cells...